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Abstract
Background: Preterm birth is the leading cause of all infant mortality. In 2004, 12.5% of all births
were preterm. In order to understand preterm labor, we must first understand normal labor. Since
many of the myometrial changes that occur during pregnancy are similar in mice and humans and
mouse gestation is short, we have studied the uterine genes that change in the mouse during
pregnancy. Here, we used microarray analysis to identify uterine genes in the gravid mouse that are
differentially regulated in the cyclooxygenase-1 knockout mouse model of delayed parturition.
Methods:  Gestational d18.0 uteri (n = 4) were collected from pregnant wild-type and
cyclooxygenase-1 knockout mice. Part of the uterus was used for frozen sections and RNA was
isolated from the remainder. Microarray analysis was performed at the Indiana University School
of Medicine Genomic Core and analyzed using the Microarray Data Portal. Northern analysis was
performed to confirm microarray data and the genes localized in the gravid uterus by in situ
hybridization.
Results:  We identified 277 genes that are abnormally expressed in the gravid d18.0
cyclooxygenase-1 knockout mouse. Nine of these genes are also regulated in the normal murine
uterus during the last half of gestation. Many of these genes are involved in the immune response,
consistent with an important role of the immune system in parturition. Expression of 4 of these
genes; arginase I, IgJ, Tnfrsf9 and troponin; was confirmed by Northern analysis to be mis-regulated
during pregnancy in the knockout mouse. In situ hybridization of these genes demonstrated a
similar location in the gravid wild-type and Cox-1 knockout mouse uteri.
Conclusion: To our knowledge, this is the first work to demonstrate the uterine location of these
4 genes in the mouse during late pregnancy. There are several putative transcription factor binding
sites that are shared by many of the 9 genes identified here including; estrogen and progesterone
response elements and Ets binding sites. In summary, this work identifies 9 uterine murine genes
that may play a role in parturition. The function of these genes is consistent with an important role
of the immune system in parturition.
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Background
In 2004 12.5% of all births in the USA were preterm [1].
Preterm birth is the leading cause of all infant mortality
and a major cause of morbidity [2-4]. The reason that idi-
opathic preterm labor remains an enigma is that the
mechanisms that initiate normal labor are largely
unknown. Parturition has been studied in many species,
but there is no perfect animal model of human labor [5].
Mouse models are useful to study parturition because ges-
tation is short (19.5 days) and genetically modified mod-
els are readily available [6]. In addition, some of the
uterine changes that occur in pregnancy are similar in
mice and humans [6-8].
Gene knockouts of prostaglandin synthesis enzymes and
receptors have demonstrated the importance of the pros-
taglandin synthesis pathway for normal murine parturi-
tion [9-12]. Cyclooxygenase-1 (Cox-1) and Cox-2 catalyze
the first committed step in prostaglandin synthesis. Cox-1
and Cox-2 have similar structure and are both inhibited
by the nonselective nonsteroidal antiinflammatory drugs,
but are regulated differently [13]. Cox-1 is constitutively
expressed in most tissues. However, induction of uterine
Cox-1 mRNA between gestational days (d) 14.5 and 15.5
and the subsequent increase in prostaglandin F2α
(PGF2α) are critical to normal timed labor in the mouse
[9,10]. In murine parturition, arachidonic acid is released
from cell membranes by cytosolic phospholipase A2
(cPLA2). Cyclooxygenase-1 (Cox-1) and prostaglandin F
synthase convert arachidonic acid to PGF2α which causes
luteolysis and a fall in progesterone resulting in induction
of uterine prostaglandin receptors, oxytocin receptor and
connexin-43, leading to increased contractions and pup
delivery [13]. In normal parturition, progesterone falls
between d17.5 and d18.5, followed by an increase
between d18.5 and d19.3 of myometrial oxytocin recep-
tor, PGF2α receptor and connexin-43 [10,14,15]. Fertility
in the Cox-1 knockout (KO) mouse is normal, but the
mice deliver their pups 2 days late. Failure of induction of
Cox-1 and PGF2α results in delayed luteolysis, high pro-
gesterone levels, decreased levels of oxytocin receptor and
connexin-43 (Muglia, unpublished results) on d19.0
(half-day prior to normal delivery) [10,16,17]. Cox-2 is
undetectable in most tissues, but can be induced to high
levels in response to inflammatory stimuli. The Cox-2 KO
mouse is infertile due to defects in ovulation, fertility,
implantation and decidualization [18]. Just before deliv-
ery, Cox-2 is induced in the myometrium, but does not
appear to be important for normal timing of parturition
[19-21].
The cPLA2 and PGF2α receptor KO mice also fail to deliver
their pups normally and demonstrate failure to induce
prostaglandin receptors, oxytocin receptor and connexin
43 [10,11,16,19,20]. Bilateral ovariectomy or administra-
tion of a progesterone antagonist (RU-486) induces uter-
ine oxytocin receptor and connexin-43 and leads to pup
delivery within 16–24 hours in the Cox-1, cPLA2 and
PGF2α receptor KO mice. Administration of PGF2α also
induces delivery in the Cox-1 and cPLA2  KO mice
[10,11,16,19,21-23]. Since some parturition-related genes
have low levels in these murine models that deliver their
pups late but are increased to normal after labor is
induced, we hypothesized that the Cox-1 KO mouse
model of delayed parturition will be useful in identifying
other genes important in the parturition pathway.
Microarray analysis identifies hundreds of uterine genes
that change during pregnancy [24-26]. Using a cut-off of
2-fold, 504 uterine genes were identified by microarray
analysis that are up- or down-regulated on gestational
d16.5 or d19.0 compared to d13.5 in the gravid wild-type
mouse [24]. To reduce this list of potential parturition-
related genes, we compared the uterine gene expression
profiles of the gravid d18.0 Cox-1 KO and wild-type mice.
By identifying uterine genes that are regulated in normal
pregnancy and abnormally expressed in the Cox-1 KO
model of delayed parturition, we hypothesized that the
number of candidate genes for roles in parturition would
be reduced.
In normal mouse pregnancy, but not in the Cox-1 KO
mouse, increased uterine PGF2α leads to luteolysis fol-
lowed by a fall in progesterone between d17.5 and d18.5
[10,15]. For this study, we wished to identify uterine genes
activated or repressed by the parturition cascade, inde-
pendent of progesterone-regulation. Therefore, we har-
vested uteri from pregnant mice on gestational d18.0.
In summary, we have identified 277 uterine genes that are
abnormally expressed in the gravid d18.0 Cox-1 KO
mouse. From these genes we have identified 9 uterine
genes that are also regulated during normal murine preg-
nancy and thus may play a role in normal parturition.
Methods
Animal husbandry
All mouse protocols were in accordance with National
Institutes of Health guidelines and approved by the Insti-
tutional Animal Care and Use Committee of Indiana Uni-
versity School of Medicine (Indianapolis, IN). All mice
used were 8–16 wks old and of a C57BL/6 (wild-type) or
C57BL/6 × 129P2 (Cox-1 KO) genetic background. Mice
were housed on a 12-h light, 12-h dark cycle with ad libi-
tum access to rodent chow and water. Mating of estrous
females to stud males was confirmed via detection of a
copulation plug, with the morning of plug detection des-
ignated as d0.5 of gestation. Plugged females were
removed from the male cage to ensure accurate gestation
timing. Non-gravid (n = 2), gravid gestational d13.5,Reproductive Biology and Endocrinology 2007, 5:28 http://www.rbej.com/content/5/1/28
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d16.5, d18.0 and d19.0 wild-type (n = 3–4) and Cox-1 KO
mice (n = 3–4) as well as gestational d20.0 and d21.0 Cox-
1 KO mice were euthanized by CO2 inhalation, and then
the uteri were quickly isolated. The fetuses, fetal mem-
branes and placenta were removed. Three pieces of uterus
from each mouse were fixed in 4% paraformaldehyde,
dehydrated in 10% sucrose and embedded in OCT
(Sakura Finetek, Torrance, CA), for sectioning on a cryo-
stat. The remainder of the uterus was snap frozen in liquid
nitrogen and kept at -80°C until RNA was isolated.
RNA isolation and microarray analysis
Gestational d18.0 RNA (n = 4 for each genotype) was iso-
lated using Trizol (Invitrogen, Carlsbad, CA) and further
purified using an RNeasy Mini Kit (Qiagen, Valencia, CA)
and dissolved in Rnase-free water. RNA from all other
time points was isolated using Trizol only. The A260/A280
was 1.55 – 1.69 for all Rneasy purified samples. The A260/
A280 for Trizol-purified RNA was 1.43–1.6. Integrity of
RNA was further checked on a 1.2% formaldehyde agar-
ose gel. Concentration of RNA was determined by the A260
and amounts adjusted according to the relative intensities
of the 28S band on the test gel. Approximately 200–300
μg of RNA was isolated from each uterus. The Center for
Medical Genomics Core at Indiana University School of
Medicine analyzed the RNA using Affymetrix 430 2.0
GeneChips. Five μg of total RNA was labeled following
single cycle protocols recommended in the GeneChip
Expression Analysis Technical Manual (Affymetrix, Santa
Clara, CA). The cDNA was synthesized from RNA using a
T7 promoter-dT24 oligonucleotide primer with the Invit-
rogen Life Technologies SuperScript Choice system. After
the second strand synthesis and incubation with T4 DNA
polymerase the products were purified using an Affyme-
trix Cleanup Module. Biotynylated cRNA was made using
the Affymetrix IVT kit. The cRNA was purified with Qiagen
RNeasy columns, quantitated and then fragmented at
high temperature with magnesium. Fifteen μg of bioti-
nylated cRNA was added to a total hybridization cocktail
of 300 μL and 200 μL was hybridized to a 430 2.0 Gene-
Chip at 45° for 17 h with constant rotation. The Gene-
Chips were washed, stained with phycoerythrin-labeled
streptavidin, washed, incubated with biotinylated anti-
streptavidin and then restained with phycoerythrin-
lableled streptavidin to amplify the signals, all following
the standard Affymetrix protocol. In order to reduce non-
random error, balanced groups of samples were handled
in parallel. GeneChips were then scanned using a dedi-
cated scanner controlled by Affymetrix GCOS software.
The images were examined for defects and the hybridiza-
tion intensity data was analyzed with the Affymetrix
Microarray Suite version 5 (MAS5). MAS5 calculated a set
of metrics that describe probe performance. The average
intensity on each array was normalized by global scaling
to a target intensity of 1000. Data were imported into the
MicroArray Data Portal for further analysis. All genes
included in the analysis had to have a "present" call in at
least 50% of the samples. Significance was determined by
a Student's t test of the log-transformed signal with a
Welch's correction. Gene changes were considered signifi-
cant if the p value was less than or equal to 0.05 and the
fold-change was at least 1.5. Expression levels of all genes
on the GeneChips are available under GEO accession
number GSE8269 [27].
In situ hybridization
The paraformaldehyde fixed uteri were cryopreserved in
10% sucrose in PBS and then embedded in OCT com-
pound (Sakura Finetek, Torrance, CA) for sectioning on a
cryostat. Sixteen-micrometer cryostat sections through the
uteri were collected and thaw-mounted onto Superfrost
plus slides. The slides were vacuum dried overnight and
stored at -80°C [28]. RNA probes were prepared with α-
33P-uridine triphosphate (Perkin Elmer, NJ) by incubating
2  μg of the linearized template with the appropriate
polymerase using the Promega Riboprobe System [29].
RNA probes for arginase I [GenBank: NM_007482] and
IgJ [GenBank: NM_152839] were transcribed from mouse
EST clones (ATCC, Manassas, VA) using T7 polymerase.
For Tnfrsf9 [GenBank: NM_011612] and Tnni2 [Gen-
Bank: NM_009405] RNA from gravid d13.5 normal
mouse uteri was reverse transcribed and then amplified
using specific primers designed by Oligoperfect (Invitro-
gen, Carlsbad, CA) (Table 1). The PCR products were
TOPO cloned (Invitrogen, Carlsbad, CA) following the
manufacturer's instructions. DNA was isolated from the
bacterial culture using Qiagen Maxi kit (Valencia, CA).
Both Tnfrsf9 and Tnni2 were linearized with EcoRI. Unin-
corporated nucleotides were removed by purifying the
riboprobe over a Sephadex G50 column (Roche). Probes
were used at a concentration of 1 × 106 cpm/mL of the
radiolabel. Slides were hybridized to the appropriate anti-
sense riboprobes in a humidified chamber for 20 h at
62°C for IgJ and 60°C for all other probes as described
[28]. After washes, with the most stringent wash in 0.1 ×
SSC at 65°C for 30 min, and vacuum drying, slides were
exposed to BioMax MR film (Kodak, Rochester, NY) for 1–
2 days. Slides were dipped in NBT Autoradiography emul-
sion (Kodak) and exposed for 4 days (Tnfrsf9) or 8 days
(arginase, IgJ and Tnni2). Emulsion dipped slides were
developed and fixed using D-19 Developer and Fixer
(Kodak). Slides were counterstained with hematoxylin
and eosin. Sense probes were generated from the same
EST clones used for the antisense probes. Sense templates
were linearized with Not I. Arginase and IgJ sense tem-
plates were transcribed with SP6 polymerase. Tnfrsf9 and
Tnni2 sense templates were transcribed with T7 polymer-
ase. The sense probes were incubated under the identical
conditions and the emulsion was exposed for the identical
length of time as the corresponding antisense probes.Reproductive Biology and Endocrinology 2007, 5:28 http://www.rbej.com/content/5/1/28
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Four mice from each gravid time point were analyzed for
in situ hybridization. Since we were focusing on gravid
uterus, only 2 wild-type uteri were analyzed. A represent-
ative slide from each time point is shown in the figures.
Northern blots
Northern analysis was performed as described previously
[28]. Ten μg of RNA was separated on a 1.2% formalde-
hyde agarose gel and transferred overnight to nitrocellu-
lose membranes. RNA on the blots were fixed by vacuum
drying at 80°C (2 hours). RNA probes specific for mouse
arginase I, IgJ, Tnfrsf 9, Tnni2 or cyclophilin A (as a load-
ing control) (Ambion, Austin, TX) labeled with α-
[32P]UTP (Perkin Elmer, Wellesley, MA) were generated as
described for the in situ probes above. The blots were
hybridized with the appropriate probe at 65°C overnight
in 50% formamide-containing buffer. After being washed,
the blots were used to expose Biomax-MS film (Kodak).
Each mRNA hybridization signal was corrected for load-
ing and recovery by normalization to the intensity of
cyclophilin A hybridization. The films were scanned into
Photoshop using an Epson Perfection 3490 Photo scan-
ner. The band intensities were quantitated using NIH
Image J [30]. A two-tailed ANOVA was used to determine
statistical significance. For d18.0 samples 5 mice of each
genotype were used. Only 3 mice from all other time
points were used to be able to fit all of the Cox-1 KO sam-
ples on a single gel. The wild-type and Cox-1 KO blots
were incubated at the exact same time in the same cylinder
with radiolabeled probe so that relative expression levels
could be compared.
Transcription factor binding sites
Putative binding sites for each gene were determined
using the VISTA browser and rVISTA program [31-34].
Only putative transcription factor binding sites that were
conserved in both the mouse and human genes were iden-
tified.
Results and discussion
Despite advances in medical technology, the incidence of
preterm birth continues to increase and is the leading
cause of infant mortality. We have had only limited suc-
cess in preventing preterm labor because normal labor is
not completely understood. We have studied parturition
in the mouse because gestation is short and genetic
manipulation of the mouse is relatively easy. We hypoth-
esized that uterine genes that are abnormally expressed in
a mouse model of delayed parturition may play roles in
normal parturition and be good targets for therapeutic
prevention of preterm labor. Since the Cox-1 KO mouse
delivers its pups 2 days late, we compared uterine gene
expression from the gravid d18.0 Cox-1 KO and wild-type
mice. In order to reduce the number of candidate parturi-
tion-related genes identified we compared the genes iden-
tified as abnormally expressed in the Cox-1 KO uterus to
the genes that we had previously identified as changing
from gestational d13.5 to d19.0 in the wild-type mouse
uterus [24]. Microarray analysis was performed on gravid
d18.0 wild-type (n = 4) and Cox-1 KO (n = 4) mouse uter-
ine RNA. We detected 277 genes that were either up- or
down-regulated at least 1.5 fold in the Cox-1 KO uterus (p
< 0.05) (See additional file 1: Excel table 1 for all 277
genes identified.). The majority of these genes did not
change significantly between d13.5 and d19.0 in the
gravid wild-type uterus. However, 9 of these genes are reg-
ulated in the wild-type gravid mouse uterus after the
induction of Cox-1 (d19.0 compared to d13.5) (Tables 2
and 3). The function of several of the 9 identified genes
involves the immune system. Other functions include
proteolysis, contraction regulation and a regulator of
nitric oxide synthase.
Gestational d18.0 was chosen to obtain the latest point in
gestation before effects from differences in progesterone
levels in the Cox-1 KO and wild-type mice would affect
gene expression. To confirm that progesterone differences
did not affect expression of the identified genes, we com-
pared expression of 16 known progesterone-regulated
uterine genes in the wild-type and knockout mice (Table
4) [35-38]. Kallikrein 6 (Klk6), which is up-regulated in
response to acute progesterone exposure, was decreased in
the Cox-1 KO mice. However, none of the other 15 known
progesterone-regulated genes showed a significant differ-
ence in expression levels in the Cox-1 KO compared to
wild-type mice (Table 4). This is consistent with the differ-
ences in uterine gene expression seen in the Cox-1 KO
Table 2: Uterine genes regulated in normal mouse pregnancy 
and up-regulated in the gravid d18.0 Cox-1 KO mouse
Gene Symbol Genbank Cox-1 KO vs WT1 Fold (d19/d13.5)a
IgJ NM_152839 5.8 3.1
Arg1 NM_007482 1.8 4.6
Gzme NM_010373 1.5 -10.0
Tnfrsf9 NM_011612 1.5 -2.5
1COX-1 KO (knockout) mouse compared to WT (wild-type) by 
microarray analysis. aBethin et al. 2003; fold difference in wild-type 
gravid mouse uterus on d19.0 compared to d13.5 by microarray. p 
values are all < 0.05
Table 1: Primers used to amplify Tnfrsf 9 and Tnni2 from gravid 
d13.5 mouse uterus.
Gene Direction Sequence Exons
Tnfrsf9 Forward 5'CTAGTGGGCTGTGAGAAGGT3' 3–9
Reverse 5'TCCTCCTTCTTCTTCCTGTG3'
Tnni2 Forward 5'GGAGACAGCACCTGAAGAGT3' 3–6
Reverse 5'CCGTTCCTTCTCAGTGTCTT3'Reproductive Biology and Endocrinology 2007, 5:28 http://www.rbej.com/content/5/1/28
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mice on d18.0 being independent of progesterone regula-
tion.
From the 9 candidate genes we chose the 3 genes that were
up-regulated the most and one of the genes that was
down-regulated the most in the Cox-1 KO mice compared
to the wild-type mice to study further by Northern analy-
sis: arginase I (liver type), immunoglobulin J chain (IgJ),
tumor necrosis factor receptor superfamily 9 (Tnfrsf9) and
troponin I (Tnni2) (skeletal, fast) (Fig. 1). In situ hybridi-
zation showed that all 4 genes were expressed in the same
location and distribution in the Cox-1 KO mouse and the
wild-type mice (Figs. 2, 3, 4). There was no hybridization
signal detected for any of the sense probes for these genes
(data not shown). Northern analysis was also done on
gravid uterus from wild-type d13.5, d16.5 and d19.0 (n =
3) and Cox-1 KO d13.5, d16.5, d19.0, d20.0 and d21.0 (n
= 3) mice (Fig. 5). The results were consistent with the rel-
ative expression levels demonstrated on the microarray
analysis for the wild-type mice. Northern analysis was not
done on the remaining genes. However, in situ hybridiza-
tion was performed on Klk6, Gem, Cftr and Atp8a1 (data
not shown) and the signal intensity qualitatively agreed
with the microarray data. In situ hybridization of arginase,
Tnfrsf9 and Tnni2 d18.0 looked similar to d19.0 in situs
(data not shown).
Arginase I (AI) expression on d18.0 was 1.9- and 1.8- fold
greater in the Cox-1 KO uterus (p = 0.004), by Northern
and microarray analysis, respectively (Fig. 1, Table 2).
Expression of AI is limited to a small part of the
endometrium in the gravid uterus (Figs. 2 &3). By micro-
array analysis AI expression in the gravid wild-type uterus
is increased 4.6-fold on d19.0 compared to d13.5 [24]. By
Northern analysis, there is a trend for AI expression to
increase on d19.0 compared to d13.5 in both the wild-
type and Cox-1 KO mice but this did not meet statistical
significance (Fig. 5). AI is primarily expressed in the liver
but has been found in other cells, including the
endometrium [39-43]. AI catalyzes the hydrolysis of
arginine to urea and ornithine thus inhibiting nitric oxide
synthase as well as controlling DNA, RNA and protein
synthesis [44]. Pregnancy or administration of estradiol
increases uterine arginase activity [45,46]. AI RNA has
been shown to be present in the non-gravid mouse
endometrium, but to our knowledge has not been evalu-
ated in mouse pregnancy [39]. In the pregnant mouse, AI
may be both providing substrate for growth of the fetus
and placenta and promoting uterine contractions by inhi-
bition of nitric oxide synthase [45-50]. Our data are con-
sistent with a factor other than Cox-1 produced
prostaglandins inducing AI in the uterus. Inhibition of
Cox-2 but not Cox-1 has been shown to reduce arginase
activity [51]. Increased T helper2 (Th2) cytokines in the
Cox-1 KO mouse may be responsible for the higher levels
of AI in the Cox-1 KO mouse [52]. Induction of AI at the
end of pregnancy in both wild-type and knockout mice
could be augmenting uterine contractions via inhibition
of nitric oxide synthase. Increased arginase I in the Cox-1
KO may compensate for failure of the normal parturition
genes to be activated allowing nitric oxide synthase to be
inhibited enough that the Cox-1 KO mice finally deliver
their pups.
Immunoglobulin J chain (IgJ) is expressed late in B cell
maturation and is important for the primary immune
response [53]. IgJ is present in non-pregnant human
endometrium, up-regulated in laboring human myo-
metrium and is present in fetal membranes and decidua
during the first trimester of pregnancy [26]. By microarray
analysis, IgJ is up-regulated 2.7-fold between gestational
d13.5 and d16.5 in the pregnant wild-type mouse suggest-
ing that the factor regulating Cox-1 induction may also be
regulating B cell and IgJ induction [24]. By Northern anal-
Table 3: Uterine genes regulated in normal mouse pregnancy 
and down-regulated in the gravid d18.0 Cox-1 KO mouse
Gene Symbol Genbank Cox-1 KO vs WT1 Fold (d19/d13.5)a
Klk6 NM_010639 -1.5 -2.5
Gem NM_010276 -1.5 -2.0
Cftr NM_021050 -1.5 2.5
Atp8a1 NM_009727 -1.6 11.0
Tnni2 NM_009405 -1.6 -5.0
1COX-1 KO (knockout) mouse compared to WT (wild-type) by 
microarray analysis. aBethin et al. 2003; fold difference in wild-type 
gravid mouse uterus on d19.0 compared to d13.5 by microarray. p 
values are all < 0.05
Table 4: Fold-change in the gravid d18.0 Cox-1 KO mouse uterus 
known progesterone-regulated genes compared to wild-type
Gene Symbol Cox-1 KO vs. WT GenBank
Ihh 1.09 NM_010544
Fst 1.01 NM_008046
Areg signal too low NM_009704
Hdc 1.08 NM_008230
Hoxa10 -1.09 NM_008263
Hoxa11 -1.12 NM_010450
IGF-1 -1.36 NM_184052
Irg1 -1.24 L38281
PR -1.04 NM_008829
Calca 1.2 NM_007587
Klk6 -1.48* NM_010639
MMP11 1.2 NM_008606
CSPG2 1.1 NM_001081249
Col6A3 -1.02 NM009935
Cdh11 -1.25 NM_009866
Cst3 1.03 NM_009976
1Expression by microarray analysis in the Cox-1 KO (knockout) 
compared to WT (wild-type) mice.
* p < 0.05Reproductive Biology and Endocrinology 2007, 5:28 http://www.rbej.com/content/5/1/28
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ysis IgJ expression increases in both the wild-type and
Cox-1 KO mice between d13.5 and d16.5 and is higher in
the gravid Cox-1 KO mouse at all time points (Fig 5). On
d18.0, Immunoglobulin J (IgJ) expression is increased
6.2-fold (p = 0.0003) by Northern and 5.8-fold by micro-
array in the Cox-1 KO mouse (Fig. 1, Table 2). IgJ is
expressed in distinct cells in the endometrium (Fig. 4).
These data are consistent with increased Th2 cytokines in
the Cox-1 KO mouse stimulating B cell proliferation in
the gravid uterus, resulting in increased IgJ expression. IgJ
is likely playing a role in parturition involving immune
system activation near the end of pregnancy. Its expres-
sion appears to be related to a parturition signal that is
simultaneous with or earlier than the induction of Cox-1.
Tumor necrosis factor receptor superfamily 9 (Tnfrsf9, 4-
1BB, CD137) is expressed in immune cells, including pla-
cental macrophages, and plays an important role in the
regulation of the immune response [54]. Activation of
Tnfrsf9 induces proliferation of both CD8+ and CD4+ T
cells and has been shown to induce rejection of tumors,
enhance T cell response to viruses, reduce autoimmune
disease progression and suppresses Th2  cells [54,55].
Tnfrsf9 uterine expression on d18.0 is 2.7- and 1.5- fold
higher (p = 0.0003) in the Cox-1 KO uterus than the wild-
type mouse by Northern and microarray analysis, respec-
tively (Fig. 1, Table 2). By microarray analysis Tnfrsf9
mRNA is down-regulated 2-fold between d13.5 and d19.0
in the gravid wild-type uterus [24]. This was confirmed by
Northern analysis, which also demonstrated a decrease
between d13.5 and d19.0 in the gravid Cox-1 KO (Fig. 5).
In the pregnant mouse, uterine Tnfrsf9 is present in the
implantation site (Figs 2 &3). The role of down-regulation
of Tnfrsf9 in pregnancy may be to induce Th2 cells which
then induce arginase and IgJ. Our data suggest that pros-
taglandins may suppress Tnfrsf9 but are not the major reg-
ulator since Tnfrsf9 decreases in the Cox-1 KO mice as
well.
Troponin I type 2 (Tnni2) inhibits the actomyosin ATPase
and provides a calcium-sensitive switch for muscle con-
traction and also directly inhibits calcium flux by binding
the ryanodine receptor [56-58]. On d18.0 expression of
Tnni2 is decreased in the Cox-1 KO to 1.6-fold of the wild-
type mice (p = 0.0005) by Northern and microarray anal-
ysis (Fig. 1, Table 3). Tnni2 is expressed in the circular
layer of the myometrium (Figs. 2 &3). To our knowledge,
this is the first report of Tnni2 in the gravid uterus. Micro-
array analysis shows that Tnni2 expression decreases 5.9-
fold between d13.5 and d19.0 in the gravid wild-type
mouse uterus. Northern analysis confirms these data and
demonstrates a decrease in Tnni2 expression earlier in the
Cox-1 KO on d16.5 (Fig. 5). Tnni2 in the gravid uterus
may be helping to maintain the uterus in a quiescent state
both directly by inhibiting actomyosin and indirectly by
inhibiting calcium influx. In prepubertal rats, high dose
estrogen down-regulates uterine Tnni2 [59]. In rodent
pregnancy, estradiol increases just prior to delivery [6,60].
In wild-type mice, the fall in Tnni2 appears to correspond
with the normal increase in estrogen just prior to delivery.
The earlier decrease of Tnni2 in the Cox-1 KO mouse sug-
gests that another factor also regulates Tnni2.
Blot and graph of Northern analysis of arginase, immunoglobulin J chain, Tnfrsf9 and troponin levels from gravid d18.0 wild- type (WT) and Cox-1 KO uteri (n = 5) Figure 1
Blot and graph of Northern analysis of arginase, immunoglobulin J chain, Tnfrsf9 and troponin levels from 
gravid d18.0 wild-type (WT) and Cox-1 KO uteri (n = 5). Error bars show the standard error.
Day 18.0 Gene Expression
0
20000
40000
60000
80000
100000
120000
140000
160000
Arginase I IgJ Tnfrsf9 Tnni2
R
e
l
a
t
i
v
e
 
E
x
p
r
e
s
s
i
o
n
Wild-type
Cox-1 KO
* p < 0.05 compared to wild-type mouse
*
*
* *Reproductive Biology and Endocrinology 2007, 5:28 http://www.rbej.com/content/5/1/28
Page 7 of 11
(page number not for citation purposes)
In an effort to find similarities among the 9 genes that
have abnormal expression levels in the Cox-1 KO uterus
and are regulated after d13.5 in the wild-type mouse, the
promoter regions of each gene and Cox-1 were evaluated
with rVISTA. Seven of the genes contain at least 1 estrogen
response element and at least 1 putative Ets binding site.
In addition, 6 genes contain a putative Gli binding site
and 5 genes contain a putative progesterone response ele-
ment (Table 5). Gli3 is a zinc finger transcription factor
that is a downstream mediator of the sonic hedgehog
pathway [61]. It is expressed from early in development
through adulthood. It has been described in both the
human and murine uterus and may play a role in implan-
tation [62,63]. Elf3 is a member of the Ets family of tran-
scription factors whose expression is limited to the
epithelium. Elf3 is important for development of the
intestine, but its role in the uterus is unknown [64]. By
microarray analysis of gravid wild-type murine uterus Elf3
and Ets2 are increased on d19.0, 5.0-and 1.7-fold, respec-
tively, compared to d13.5 [24]. On d18.0 we did not see a
difference between the Cox-1 KO and wild-type mice in
either of these transcription factors. Therefore, Elf3 and
Ets2 could only be modifying transcription of parturition
genes on d18.0 if estrogen and/or PGF2α modify the
binding of these transcription factors. Gli3 levels on d19.0
decrease to 18% of d13.5 in the gravid wild-type mouse,
but no differences in Gli3 levels were detected in the Cox-
1 KO mouse [24]. Estradiol increases and progesterone
decreases near term in the pregnant mouse [6,60]. Since
progesterone-regulated genes were unaffected in the
d18.0 Cox-1 KO mouse, estrogen is likely playing a larger
role than progesterone in these gene changes.
There are numerous differences between murine and
human pregnancy. The maintainence of the corpus
luteum in mice maintains pregnancy but has no role after
the first trimester in humans. Although Cox-1 is critical
for normal labor in the mice, it is the Cox-2 isoform that
appears to be important in human labor. However, pros-
In situ hybridization for arginase, Tnfrsf9, and Tnni2 in the  gravid d165 and d19.0 wild-type and Cox-1 KO mouse uteri Figure 3
In situ hybridization for arginase, Tnfrsf9, and Tnni2 
in the gravid d16.5 and d19.0 wild-type and Cox-1 KO 
mouse uteri. In situ hybridization was performed (n = 4) 
from each gravid time point. Shown are representative light-
field images (left) and dark-field images (right) from gravid 
d16.5 and d19.0 uteri (25×). The slides were counterstained 
with hematoxylin and eosin. Areas of hybridization appear 
white, demonstrating deposition of silver granules.
In situ hybridization for arginase, Tnfrsf9, and Tnni2 in the  non-gravid and gravid d13.5 wild-type and Cox-1 KO mouse  uteri Figure 2
In situ hybridization for arginase, Tnfrsf9, and Tnni2 
in the non-gravid and gravid d13.5 wild-type and Cox-
1 KO mouse uteri. In situ hybridization was performed on 
(n = 4) each gravid time point and (n = 2) non-gravid mice. 
Shown are representative light-field images (left) and dark-
field images (right) from non-gravid (NG) (50×) or gravid 
d13.5 uteri (25×). The slides were counterstained with 
hematoxylin and eosin. Areas of hybridization appear white, 
demonstrating deposition of silver granules.Reproductive Biology and Endocrinology 2007, 5:28 http://www.rbej.com/content/5/1/28
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taglandins play a key role in myometrial contractions in
both mice and humans and studies in knockout mice con-
tinues to be useful in elucidating the hormonal milieau of
pregnancy [9].
Conclusion
Although care of the infant born too soon has dramati-
cally improved over the last 40 years, the incidence of pre-
term births continues to rise [65]. One of the major
reasons that we have had only limited success in treating
preterm labor is that we do not fully understand normal
labor. Up to 50% of preterm births can be attributed to
infection [66]. However, idiopathic preterm labor contin-
ues to represent a large percentage of the preterm births.
There are data that implicate genetics in the timing of
labor, including preterm and postterm delivery [67-70].
We hypothesized that a mouse model of delayed parturi-
tion would help us identify genes that are important in
normal labor and thus provide possible targets for treating
preterm labor. This work identified 9 uterine genes that
are regulated during murine pregnancy and demonstrate
abnormal levels in the gestational d18.0 Cox-1 KO
mouse. We have confirmed these data by Northern analy-
sis for 4 genes: arginase I, IgJ, Tnfrsf9 and Tnni2. We also
demonstrated the location of these genes in the gravid
mouse uterus. To our knowledge, this is the first time
these genes have been investigated and localized in the
late pregnant mouse uterus. Of the 4 genes studied,
Tnfrsf9, IgJ and arginase I play a role in the immune sys-
tem. These data are consistent with an important role for
the immune system, especially Th2 cells, in parturition.
These data are consistent with the works of others impli-
cating immune modulators in both pregnancy mainte-
nance and parturition [65]. These data also suggest that
studying immune system modifiers that affect Th2 cells,
specific inhibitors of arginase I and the effects of arginine
on uterine contractility may help identify new drugs for
the treatment of preterm labor. Drugs that increase expres-
sion of Tnni2, which we identified as decreasing at the end
of normal pregnancy, may help maintain uterine quies-
cence and are another promising area of research related
to preterm labor. Since many of the genes identified in
this work have putative binding sites for Gli3 and Elf3, 2
transcription factors that are up- or down-regulated in the
uterus of pregnant wild-type mice, targeting these tran-
scription factors may also affect the timing of labor. Inter-
estingly, despite a deficiency in Cox-1 derived
prostaglandins in the Cox-1 KO mouse, none of the gene
changes in this delayed model of parturition appear to be
the result of decreased prostaglandins.
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Table 5: Conserved putative transcription factor binding sites in 
the mouse and human sequences of the genes identified
Gene Symbol ERE1 ETS GLI PRE2
IgJ Yes Yes Yes
Coro1a Yes Yes Yes Yes
Arg1 Yes Yes Yes
Gzme
Tnfrsf9 Yes
Klk6
Gem Yes Yes Yes Yes
Cftr Yes Yes Yes Yes
Atp8a1 Yes Yes Yes Yes
Tnni2 Yes Yes Yes Yes
Cox-1 Yes Yes Yes
1ERE = estrogen response element, 2PRE = progesterone response 
element
In situ hybridization for IgJ in the gravid d13.5, d16.5, d18.0  and d19.0 wild-type and Cox-1 KO mouse uteri Figure 4
In situ hybridization for IgJ in the gravid d13.5, d16.5, 
d18.0 and d19.0 wild-type and Cox-1 KO mouse uteri. 
In situ hybridization was performed (n = 4) from each gravid 
time point and non-gravid mice (n = 2). Shown are repre-
sentative light-field images (left) and dark-field images (right) 
(25×). The slides were counterstained with hematoxylin and 
eosin. Areas of hybridization appear white, demonstrating 
deposition of silver granules.Reproductive Biology and Endocrinology 2007, 5:28 http://www.rbej.com/content/5/1/28
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